Resistant starch intake partly restores metabolic and inflammatory alterations in the liver of high-fat-diet-fed rats

Journal of Nutritional Biochemistry

Volumn 24, Issue 11, 2013, Pages 1920-1930

  Polakof, Sergio ^a,b   Díaz Rubio, María Elena ^a,b   Dardevet, Dominique ^a,b   Martin, Jean François ^a,b,c   Pujos Guillot, Estelle ^a,b,c   Scalbert, Augustin ^a,b   Sebedio, Jean Louis ^a,b   Mazur, Andrzej ^a,b   Comte, Blandine ^a,b  

^a UNIVERSITÉ CLERMONT AUVERGNE   (France)

^b CRNH AUVERGNE   (France)

^c INRA and University of Auvergne   (France)

Author keywords

Glucose and lipid metabolism; Insulin resistance; Liver; Resistant starch

Indexed keywords

PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; STARCH;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CECUM; CHOLESTEROL METABOLISM; CONTROLLED STUDY; DYSLIPIDEMIA; FATTY ACID OXIDATION; GENE EXPRESSION; GLUCONEOGENESIS; GLUCOSE HOMEOSTASIS; GLUCOSE TOLERANCE; GLUCOSE TRANSPORT; GLYCOLYSIS; INFLAMMATION; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID DIET; LIPOGENESIS; LIVER METABOLISM; MALE; METABOLIC SYNDROME X; METABOLOME; MUSCLE METABOLISM; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; PATHOPHYSIOLOGY; RAT;

RATTUS;

GLUCOSE AND LIPID METABOLISM; INSULIN RESISTANCE; LIVER; RESISTANT STARCH;

ANIMALS; BLOOD GLUCOSE; CECUM; DIET, HIGH-FAT; DIETARY FIBER; FECES; GLUCONEOGENESIS; GLUCOSE; GLYCOLYSIS; HEPATITIS; HOMEOSTASIS; INSULIN; INSULIN RESISTANCE; LIPID METABOLISM; LIVER; MALE; METABOLOMICS; RATS; SIGNAL TRANSDUCTION; STARCH;

EID: 84885835239     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2013.05.008     Document Type: Article

References (65)

1. Zimmet P., Alberti K.G., Shaw J. Global and societal implications of the diabetes epidemic. Nature 2001, 414:782-787.
2. Cornier M.-A., Dabelea D., Hernandez T.L., Lindstrom R.C., Steig A.J., Stob N.R., et al. The metabolic syndrome. Endocr Rev 2008, 29:777-822.
3. Weickert M.O., Pfeiffer A.F.H. Metabolic effects of dietary fiber consumption and prevention of diabetes. J Nutr 2008, 138:439-442.
4. Anderson J.W., Baird P., Davis R.H., Ferreri S., Knudtson M., Koraym A., et al. Health benefits of dietary fiber. Nutr Rev 2009, 67:188-205.
5. Galisteo M., Duarte J., Zarzuelo A. Effects of dietary fibers on disturbances clustered in the metabolic syndrome. J Nutr Biochem 2008, 19:71-84.
6. Pi-Sunyer X. Do glycemic index, glycemic load, and fiber play a role in insulin sensitivity, disposition index, and type 2 diabetes?. Diabetes Care 2005, 28:2978-2979.
7. Shimotoyodome A., Suzuki J., Fukuoka D., Tokimitsu I., Hase T. RS4-type resistant starch prevents high-fat diet-induced obesity via increased hepatic fatty acid oxidation and decreased postprandial GIP in C57BL/6J mice. Am J Physiol Endocrinol Metab 2010, 298:E652-E662.
8. Demigne C., Remesy C. Hepatic metabolism of short-chain fatty acids. Short-chain fatty acids: metabolism and clinical importance 1991, 17-23. Ross Laboratories, Columbus, OH. E. Silverman, A.F. Roche (Eds.).
9. Utzschneider K.M., Kahn S.E. The role of insulin resistance in nonalcoholic fatty liver disease. J Clin Endocrinol Metab 2006, 91:4753-4761.
10. Kotronen A., Yki-Järvinen H. Fatty liver: a novel component of the metabolic syndrome. Arterioscler Thromb Vasc Biol 2008, 28:27-38.
11. Leclercq I.A., Da Silva Morais A., Schroyen B., Van Hul N., Geerts A. Insulin resistance in hepatocytes and sinusoidal liver cells: mechanisms and consequences. J Hepatol 2007, 47:142-156.
12. Tremaroli V., Backhed F. Functional interactions between the gut microbiota and host metabolism. Nature 2012, 489:242-249.
13. Balage M., Averous J., Remond D., Bos C., Pujos-Guillot E., Papet I., et al. Presence of low-grade inflammation impaired postprandial stimulation of muscle protein synthesis in old rats. J Nutr Biochem 2010, 21:325-331.
14. Levy J.C., Matthews D.R., Hermans M.P. Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care 1998, 21:2191-2192.
15. Reynolds C.K., Huntington G.B., Tyrrell H.F., Reynolds P.J. Net metabolism of volatile fatty acids, D-beta-hydroxybutyrate, nonesterifield fatty acids, and blood gasses by portal-drained viscera and liver of lactating Holstein cows. J Dairy Sci 1988, 71:2395-2405.
16. Folch J., Lees M., Sloane-Stanley G. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 1957, 226:497-509.
17. Mazur A., Remesy C., Gueux E., Levrat M.A., Demigne C. Effects of diets rich in fermentable carbohydrates on plasma lipoprotein levels and on lipoprotein catabolism in rats. J Nutr 1990, 120:1037-1045.
18. Keppler D., Decker K., Bergmeyer H.U. Glycogen determination with amyloglucosidase. Methods of enzymatic analysis 1974, 1127-1131. Academic Press, New York.
19. Saggerson E., Greenbaum A. The regulation of triglyceride synthesis and fatty acid synthesis in rat epididymal adipose tissue. Effects of altered dietary and hormonal conditions. Biochem J 1970, 119:221.
20. Tian W.N., Braunstein L.D., Apse K., Pang J., Rose M., Tian X., et al. Importance of glucose-6-phosphate dehydrogenase activity in cell death. Am J Physiol Cell Physiol 1999, 276:C1121-C1131.
21. Corrigan A.P., Rider C.C. Multiple chromatographic forms of ATP citrate lyase from rat liver. Biochem J 1983, 214:299.
22. Davidson A.L., Arion W.J. Factors underlying significant underestimations of glucokinase activity in crude liver extracts: physiological implications of higher cellular activity. Arch Biochem Biophys 1987, 253:156-167.
23. Westbury K., Hahn P. Fructose-1,6-biphosphatase activity in the intestinal mucosa of developing rats. Am J Physiol 1984, 246:G683-G686.
24. Baly D.L., Keen C.L., Hurley L.S. Pyruvate carboxylase and phosphoenolpyruvate carboxykinase activity in developing rats: effect of manganese deficiency. J Nutr 1985, 115:872.
25. Dunaway G.A., Morris H.P., Weber G. A comparative study of rat liver, muscle, and hepatoma 3924A phosphofructokinase isozymes. Cancer Res 1974, 34:2209.
26. Sugawa-Katayama Y., Morita N. Effects of a high fructose diet on lipogenic enzyme activities in some organs of rats fed ad libitum. J Nutr 1975, 105:1377-1383.
27. Alegre M., Ciudad C.J., Fillat C., Guinovart J.J. Determination of glucose-6-phosphatase activity using the glucose dehydrogenase-coupled reaction. Anal Biochem 1988, 173:185-189.
28. Denton R.M., Edgell N.J., Bridges B.J., Poole G.P. Acute regulation of pyruvate kinase activity in rat epididymal adipose tissue by insulin. Biochem J 1979, 180:523-531.
29. Caraux G., Pinloche S. PermutMatrix: a graphical environment to arrange gene expression profiles in optimal linear order. Bioinformatics 2005, 21:1280-1281.
30. Gao X., Pujos-Guillot E., Martin J.-F., Galan P., Juste C., Jia W., et al. Metabolite analysis of human fecal water by gas chromatography/mass spectrometry with ethyl chloroformate derivatization. Anal Biochem 2009, 393:163-175.
31. Smith C.A., Want E.J., O'Maille G., Abagyan R., Siuzdak G. XCMS: processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification. Anal Chem 2006, 78:779-787.
32. Benton H.P., Wong D.M., Trauger S.A., Siuzdak G. XCMS2: processing tandem mass spectrometry data for metabolite identification and structural characterization. Anal Chem 2008, 80:6382-6389.
33. Benjamini Y., Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Stat Soc Ser B (Stat Method) 1995, 289-300.
34. Liang H., Ward W.F. PGC-1α: a key regulator of energy metabolism. Adv Physiol Educ 2006, 30:145-151.
35. Pedersen T.A., Bereshchenko O., Garcia-Silva S., Ermakova O., Kurz E., Mandrup S., et al. Distinct C/EBPalpha motifs regulate lipogenic and gluconeogenic gene expression in vivo. EMBO J 2007, 26:1081-1093.
36. Buettner R., Parhofer K.G., Woenckhaus M., Wrede C.E., Kunz-Schughart L.A., Scholmerich J., et al. Defining high-fat-diet rat models: metabolic and molecular effects of different fat types. J Mol Endocrinol 2006, 36:485-501.
37. Chen G., Liang G., Ou J., Goldstein J.L., Brown M.S. Central role for liver X receptor in insulin-mediated activation of Srebp-1c transcription and stimulation of fatty acid synthesis in liver. Proc Natl Acad Sci U S A 2004, 101:11245-11250.
38. Carrozza G., Livrea G., Caponetti R., Manasseri L. Response of rat hepatic fatty acid synthesis and activities of related enzymes to changes in level of dietary fat. J Nutr 1979, 109:162-170.
39. Van Rooyen D.M., Farrell G.C. SREBP-2: a link between insulin resistance, hepatic cholesterol, and inflammation in NASH. J Gastroenterol Hepatol 2011, 26:789-792.
40. Ferré P. The biology of peroxisome proliferator-activated receptors. Diabetes 2004, 53:S43-S50.
41. Matsunami T., Sato Y., Ariga S., Sato T., Shimomura T., Kashimura H., et al. Regulation of synthesis and oxidation of fatty acids by adiponectin receptors (AdipoR1/R2) and insulin receptor substrate isoforms (IRS-1/-2) of the liver in a nonalcoholic steatohepatitis animal model. Metabolism 2011, 60:805-814.
42. Caballero F., Fernandez A., De Lacy A.M., Fernandez-Checa J.C., Caballeria J., Garcia-Ruiz C. Enhanced free cholesterol, SREBP-2 and StAR expression in human NASH. J Hepatol 2009, 50:789-796.
43. Dejeans N., Auclair S., Henry-Berger J., Lobaccaro J.M., Mazur A. A specialized cDNA microarray (Mouse Lipid Chip) reveals hepatic overexpression of serum amyloid a in high-fat diet-fed mice. Horm Metab Res 2008, 40:228-230.
44. Vandanmagsar B., Youm Y.H., Ravussin A., Galgani J.E., Stadler K., Mynatt R.L., et al. The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nat Med 2011, 17:179-188.
45. Shoelson S.E., Lee J., Goldfine A.B. Inflammation and insulin resistance. J Clin Invest 2006, 116:1793-1801.
46. Jacobs M.D., Harrison S.C. Structure of an IkappaBalpha/NF-kappaB complex. Cell 1998, 95:749-758.
47. Glass C.K., Olefsky J.M. Inflammation and lipid signaling in the etiology of insulin resistance. Cell Metab 2012, 15:635-645.
48. Wannamethee S.G., Whincup P.H., Thomas M.C., Sattar N. Associations between dietary fiber and inflammation, hepatic function, and risk of type 2 diabetes in older men. Diabetes Care 2009, 32:1823-1825.
49. Scott K., Duncan S., Flint H. Dietary fibre and the gut microbiota. Nutr Bull 2008, 33:201-211.
50. Pedersen M.H., Lauritzen L., Hellgren L.I. Fish oil combined with SCFA synergistically prevent tissue accumulation of NEFA during weight loss in obese mice. Br J Nutr 2011, 106:1449-1456.
51. Liu X., Ogawa H., Kishida T., Ebihara K. Hypolipidaemic effect of maize starch with different amylose content in ovariectomized rats depends on intake amount of resistant starch. Br J Nutr 2009, 101:328-339.
52. Johnson T.E., Holloway M.K., Vogel R., Rutledge S.J., Perkins J.J., Rodan G.A., et al. Structural requirements and cell-type specificity for ligand activation of peroxisome proliferator-activated receptors. J Steroid Biochem Mol Biol 1997, 63:1-8.
53. de Mello V., Kolehmainen M., Pulkkinen L., Schwab U., Mager U., Laaksonen D., et al. Downregulation of genes involved in NFκB activation in peripheral blood mononuclear cells after weight loss is associated with the improvement of insulin sensitivity in individuals with the metabolic syndrome: the GENOBIN study. Diabetologia 2008, 51:2060-2067.
54. Uysal K.T., Wiesbrock S.M., Marino M.W., Hotamisligil G.S. Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature 1997, 389:610-614.
55. Perez R., Stevenson F., Johnson J., Morgan M., Erickson K., Hubbard N.E., et al. Sodium butyrate upregulates Kupffer cell PGE2 production and modulates immune function. J Surg Res 1998, 78:1-6.
56. Yu S., Matsusue K., Kashireddy P., Cao W.Q., Yeldandi V., Yeldandi A.V., et al. Adipocyte-specific gene expression and adipogenic steatosis in the mouse liver due to peroxisome proliferator-activated receptor gamma1 (PPARgamma1) overexpression. J Biol Chem 2003, 278:498-505.
57. Schwab M., Reynders V., Loitsch S., Steinhilber D., Stein J., Schroder O. Involvement of different nuclear hormone receptors in butyrate-mediated inhibition of inducible NF kappa B signalling. Mol Immunol 2007, 44:3625-3632.
58. Kabir M., Rizkalla S.W., Champ M., Luo J., Boillot J., Bruzzo F., et al. Dietary amylose-amylopectin starch content affects glucose and lipid metabolism in adipocytes of normal and diabetic rats. J Nutr 1998, 128:35-43.
59. Evenepoel P., Bammens B., Verbeke K., Vanrenterghem Y. Acarbose treatment lowers generation and serum concentrations of the protein-bound solute p-cresol: a pilot study. Kidney Int 2006, 70:192-198.
60. Hooper L.V., Midtvedt T., Gordon J.I. How host-microbial interactions shape the nutrient environment of the mammalian intestine. Annu Rev Nutr 2002, 22:283-307.
61. Newgard C.B. Interplay between lipids and branched-chain amino acids in development of insulin resistance. Cell Metab 2012, 15:606-614.
62. Eyssen H., Piessens-Denef M., Parmentier G. Role of the cecum in maintaining δ5-steroid-and fatty acid-reducing activity of the rat intestinal microflora. J Nutr 1972, 102:1501-1511.
63. Kurotani K., Sato M., Ejima Y., Nanri A., Yi S., Pham N.M., et al. High levels of stearic acid, palmitoleic acid, and dihomo-γ-linolenic acid and low levels of linoleic acid in serum cholesterol ester are associated with high insulin resistance. Nutr Res 2012, 32:669-675.
64. Velagapudi V.R., Hezaveh R., Reigstad C.S., Gopalacharyulu P., Yetukuri L., Islam S., et al. The gut microbiota modulates host energy and lipid metabolism in mice. J Lipid Res 2010, 51:1101-1112.
65. Cohen G., Raupachova J., Horl W.H. The uraemic toxin phenylacetic acid contributes to inflammation by priming polymorphonuclear leucocytes. Nephrol Dial Transplant 2013, 28:421-429.